Delivery Order SPE2DR25D3103-SPE2DR26F9P20
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $59,559.83 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units). This competitive, firm fixed-price delivery order was awarded on November 24, 2025, with an ultimate completion date of November 25, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's established role as a critical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,805.92 to AmerisourceBergen Drug Corp for the supply of Eliquis 2.5 mg tablets (60-count packaging) with a firm fixed price structure. This competitively awarded, non-set-aside contract is scheduled for completion by November 19, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,585.80 to AmerisourceBergen Drug Corp for the supply of Eliquis 2.5 mg tablets (60-count package). This firm fixed-price delivery order, issued on December 11, 2025, with an ultimate completion date of December 12, 2025, represents a routine pharmaceutical procurement under a competitive, non-set-aside award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,041.79 to AmerisourceBergen Drug Corp for the supply of Eliquis 2.5 mg tablets (60-count). This firm fixed-price delivery order, issued on November 17, 2025, with an ultimate completion date of November 18, 2025, was competitively awarded with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,259.49 to AmerisourceBergen Drug Corp for the supply of Eliquis 2.5 mg tablets (60-count units) on August 22, 2025, with an ultimate completion date of August 25, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in...
- The Defense Logistics Agency awarded a delivery order valued at $10,000.02 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) under a firm fixed-price contract. The award, issued on December 8, 2025, with an ultimate completion date of December 9, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the performing location and is a major pharmaceutical distributor providing critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, valued at $25,241.36, for the supply of Eliquis 5 mg tablets (60-count packages) with a firm fixed price contract type. This award, issued on November 3, 2025, with an ultimate completion date of November 4, 2025, represents a non-competitive, non-set-aside delivery order. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, which serves as the company's...
- The Defense Logistics Agency awarded a delivery order valued at $13,301.03 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages) with a completion date of December 12, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The award represents a single...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,827.12 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages) under a firm fixed-price contract. The delivery order was awarded on July 30, 2025, with an ultimate completion date of July 31, 2025, and represents a non-competitive, competitively awarded transaction. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency has awarded a delivery order valued at $7,892.66 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units). This non-competitive delivery order, issued on December 3, 2025, with an ultimate completion date of December 4, 2025, utilizes firm fixed pricing and represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The pharmaceutical will be delivered to the company's...
- SPE2DR25D3103Indefinite Delivery Contract
- SPE2DR25D3103-SPE2DR26F9P20Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,109.37 to AmerisourceBergen Drug Corp for the supply of Eliquis 2.5 mg tablets (60-count units) under a firm fixed price contract. The award was issued on December 12, 2025, with a completion deadline of December 15, 2025. This non-competitive delivery order will be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major pharmaceutical distributor serving federal healthcare needs. This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999 and extending through December 2026. This prime contract vehicle enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, serving customers including the Defense Health Agency and U.S. Coast Guard. The award reflects AmerisourceBergen's established capability to fulfill federal medical procurement requirements through its extensive portfolio of brand-name and generic medications, consistent with DLA's strategy to maintain critical pharmaceutical supply chains for defense and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.1k | 12/11/25 |